Nuance Mid Cap Value Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Nuance Mid Cap Value Fund Investor Class NMAVX
- NAV / 1-Day Return 14.44 / 0.00
- Total Assets 292.2M
-
Adj. Expense Ratio
1.210%
- Expense Ratio 1.190%
- Distribution Fee Level Above Average
- Share Class Type Front Load
- Category Mid-Cap Value
- Investment Style Small Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.84%
- Turnover 74%
USD | NAV as of Aug 15, 2026 | 1-Day Return as of Aug 15, 2026, 1:10 AM GMT+0
Morningstar’s Analysis NMAVX
Will NMAVX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 47.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
First American Government Obligs X | 8.37 | 24M | Cash and Equivalents |
Qiagen NV | 6.71 | 19M | Healthcare |
California Water Service Group | 6.55 | 19M | Utilities |
Marten Transport Ltd | 5.84 | 17M | Industrials |
Clorox Co | 4.83 | 14M | Consumer Defensive |
Beiersdorf AG ADR | 4.76 | 14M | Consumer Defensive |
Werner Enterprises Inc | 4.57 | 13M | Industrials |
Solventum Corp | 4.50 | 13M | Healthcare |
Charles Schwab Corp DR | 3.63 | 10M | Financial Services |
Kenvue Inc | 3.12 | 9M | Consumer Defensive |